Local Institution

Sheboygan, Wisconsin

0 studies enrolling now · 1 studies all time

What they study most

Leukemia, Lymphocytic, Acute, L2, Leukemia, Myeloid, Chronic

Studies at this site

• A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate — Completed